XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
OPERATING ACTIVITIES    
Net income $ 2,285,974 $ 1,306,997
Adjustments to reconcile net income to net cash provided by operating activities (185,913) 657,280
Net Cash Provided By Operating Activities 2,100,061 1,964,277
INVESTING ACTIVITIES    
Proceeds from sales, maturities, calls and prepayments of fixed maturity securities 1,623,112 1,359,948
Cost of fixed maturity securities purchased (2,923,357) (2,661,587)
Proceeds from sales of equity securities 117,006 179,665
Cost of equity securities purchased (434,996) (448,388)
Net change in short-term investments 305,207 487,839
Cost of other investments purchased (204,338) (159,591)
Additions to property and equipment (181,040) (155,088)
Acquisitions, net of cash acquired 207,231 3,584
Proceeds from sales of subsidiaries, net 0 (41,302)
Other 21,276 16,851
Net Cash Used By Investing Activities (1,884,361) (1,342,633)
FINANCING ACTIVITIES    
Additions to senior long-term debt and other debt 1,278,485 475,964
Repayment of senior long-term debt and other debt (716,543) (811,857)
Repurchases of common stock (389,089) (269,593)
Dividends paid on preferred stock (18,000) (18,000)
Redemption of Markel CATCo Re noncontrolling interests 0 (88,997)
Purchase of noncontrolling interests (46,492) (54,371)
Other (42,629) (32,434)
Net Cash Provided (Used) By Financing Activities 65,732 (799,288)
Effect of foreign currency rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents 13,051 993
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents 294,483 (176,651)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 4,332,034 5,221,513
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD $ 4,626,517 $ 5,044,862